Bank of America's $951 billion consumer deposit base represents a significant competitive advantage, offering cheap funding for loan growth with minimal interest costs (0.51% average yield). The bank's sticky deposit franchise, supported by high switching costs and primary checking account usage, positions it well across various interest rate scenarios. With net interest income up 9% in Q1 and shares trading at a P/E of 12.7, the stock presents a compelling value opportunity.

SpaceX has filed for an IPO with an expected valuation of $1.75 trillion or more. Several mutual funds and ETFs already offer exposure to SpaceX stock, with Baron Capital funds holding the largest weightings. Other investment vehicles including public companies like Alphabet, Bank of America, and EchoStar, as well as specialized funds like Destiny Tech 100, also provide SpaceX exposure ahead of the public offering.

Under new CEO Greg Abel, Berkshire Hathaway exited positions in Visa, Mastercard, and Amazon in Q1 2026, but maintained its large Bank of America stake (8% of portfolio, fourth-largest holding). The decision signals Berkshire's preference for fairly-valued traditional banks offering stability and income over expensive fintech companies, suggesting value-focused investing strategy.

Immix Biopharma closed an underwritten registered offering of 16.78 million shares at $8.94 per share, raising approximately $140.65 million in net proceeds. The financing was led by Morgan Stanley and BofA Securities, with participation from leading U.S. biotechnology institutional investors and mutual funds.

SpaceX has selected Goldman Sachs as lead underwriter for its highly anticipated IPO, with Morgan Stanley, Bank of America, Citigroup, and JPMorgan Chase also serving as leaders. The IPO aims to raise over $75 billion at a $1.75 trillion valuation, with BlackRock considering a $5-10 billion investment. However, SpaceX's dual-class share structure has drawn criticism from pension leaders over governance concerns.

JPMorgan Chase has maintained a 14-year dividend increase streak with two increases totaling 20% in 2025, and strong Q1 2026 results showing 13% revenue growth. However, the stock appears expensive with a P/B ratio of 2.3x versus its 5-year average of 1.8x and a yield of just 2%, below the banking sector average. The article notes the current streak follows a dividend cut during the Great Recession and suggests Bank of Nova Scotia may be a better option for income investors seeking higher yield.

Berkshire Hathaway's cash hoard has reached a record $397.4 billion under new CEO Greg Abel, growing from $373 billion left by Buffett at year-end 2025. The massive cash position reflects disciplined value investing amid historically expensive market valuations, with Berkshire selling $172.93 billion in equities since 2022 while earning 4-5% on Treasury bills. However, this conservative stance cost shareholders approximately $125 billion in foregone gains compared to S&P 500 returns over 2023-2025, particularly missing mega-cap growth stocks like Nvidia, Microsoft, and Meta.

Citigroup's stock has surged over 60% in the past year, driven by strong Q1 2026 earnings (revenues up 14%, EPS jumped to $3.06) and improving ROTCE to 13.1%. However, the stock's valuation has become less attractive, with P/B ratio rising from 0.5x to 1.1x and P/E from 6x to 15x. While still cheaper than peers, the company's turnaround appears nearly complete, suggesting limited upside ahead.

Bank of America stock is trading at a low valuation (11x forward earnings, PEG ratio of 0.92) despite being down 7% year-to-date. The bank has demonstrated strength through 11 consecutive quarters of deposit increases and a 9% year-over-year increase in net interest income. With 85% of Wall Street analysts rating it a buy and a median price target of $61.50 (suggesting 22% upside), Bank of America appears well-positioned to benefit from the current interest rate environment.

Chime Financial reported its first profitable quarter since going public with $53 million in GAAP net income on $647 million revenue (up 25% YoY). The neobank achieved profitability through technology investments and cost-cutting, with adjusted EBITDA margins reaching 18%. However, the stock is down 30% this year despite strong guidance, as investors worry about seasonal profit inflation, credit risks from its lower-income customer base, and intensifying competition from both fintech rivals and traditional banks.

Berkshire Hathaway has accumulated nearly $400 billion in cash and cash equivalents as of Q1 2026, exceeding the market capitalization of most companies. Despite Warren Buffett's preference for deploying capital into quality businesses at reasonable prices, the elevated stock market valuations (Buffett indicator at 230%) have limited acquisition opportunities. The company made only a $9.7 billion purchase of OxyChem, leaving Buffett to maintain substantial cash reserves as a strategic buffer for uncertain market conditions.

Warren Buffett explains that Berkshire Hathaway's portfolio remains concentrated in five stocks (Apple, American Express, Coca-Cola, Bank of America, and Chevron) accounting for 60% of holdings because he only invests in businesses he thoroughly understands. Buffett admits he understands fewer businesses as a percentage of the whole than a decade ago and hasn't learned new industries in quite a while, making the portfolio appear stale to growth-oriented investors. Despite this conservative approach, Berkshire's portfolio continues to perform well, with Apple being a standout performer.